Centre d’Imagerie Nucléaire

What Centre d’Imagerie Nucléaire does

Centre d'Imagerie Nucléaire (CIN), founded in September 1987 by Dr. André Champailler and Dr. Éric Gremillet, is the first private nuclear medicine service in France. Operating as a Société Civile Professionnelle (SCP) under the legal name Centre d'imagerie Nucléaire, CIN runs three sites across the Loire and Haute-Loire departments — Saint-Etienne (Hôpital Privé de la Loire campus, 1,500 m² since April 2023), Roanne (Clinique du Renaison), and Le Puy-en-Velay (Centre Hospitalier Emile Roux) — staffed by five nuclear medicine physicians and approximately 35–47 total personnel. The center conducts scintigraphy and PET-scan examinations across cardiology, oncology, neurology, endocrinology, nephrology, and digestive indications, treating roughly 20,000 patients per year.

The technical platform is built around General Electric imaging hardware. CIN deploys cardiac-specific GE Discovery NM 530c CZT semiconductor gamma cameras (two units, representing half of the four installed across the Auvergne-Rhône-Alpes region), hybrid GE Discovery NM/CT 670 CZT and 870 CZT cameras, and GE Discovery PET/CT IQ systems equipped with five BGO crystal crowns that lower tracer dose and shorten whole-body PET exams to 8–10 minutes versus ~20 minutes historically. Each site has shielded radiopharmacy hot cells for tracer preparation. The center holds ISO 9001:2015 certification across all three sites and is GDPR/CNIL compliant under French Public Health Code Article R. 1112-7.

CIN's revenue is generated on a transaction-fee basis via reimbursement from the French Sécurité Sociale and supplemental mutuelles, with tiers-payant (third-party payment) applied to most procedures; patient co-payments include €7.96 on cardiac MIBI scintigraphy and up to €26.86 on FNa PET-scan. The go-to-market is physician-referral-led, supported by an Accès Pro professional portal that delivers imaging results and EPU educational content to prescribers in the regional network, with secondary direct intake via phone, email, and an online appointment form. No external investors are present and capital social is stated at €41,952.

Name

Centre d’Imagerie Nucléaire

Legal name

Centre d'imagerie Nucléaire (CIN)

Website

https://cinse.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

1–10 employees

Short description

Centre d'Imagerie Nucléaire (CIN) is a private French nuclear medicine imaging center operating three sites in Saint-Etienne, Roanne, and Le Puy-en-Velay, delivering scintigraphy and PET-scan diagnostics to roughly 20,000 referred patients per year across cardiology, oncology, and neurology.

Ownership category

akta.pro rank

Product category

Nuclear Medicine Imaging Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

akta.pro secondary industry

Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Nuclear medicine imaging
• Scintigraphy services
• PET-scan diagnostics
• Radiopharmaceutical imaging
• Medical imaging center

Headquarters

HQ city

Saint Etienne

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Imaging Services: CIN generates revenue through reimbursement from the French social security system (Sécurité Sociale) and supplementary health insurance (mutuelles) for nuclear medicine examinations including scintigraphy and PET-scan procedures. Third-party payment (tiers-payant) is practiced for most examinations.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Centre d'Imagerie Nucléaire (CIN) is a private nuclear medicine imaging center operating three sites in Saint-Étienne, Roanne, and Le Puy-en-Velay (Loire and Haute-Loire, France). It delivers diagnostic scintigraphy (cardiac, bone, pulmonary, thyroid, cerebral, renal, digestive, sentinel node) and PET-scan examinations (FDG, F-Choline, F-Dopa, PSMA, DOTATOC, FNa) using radiopharmaceuticals, along with selected molecular therapies, to approximately 20,000 patients annually referred by prescribing physicians.

Product overview

Centre d'Imagerie Nucléaire (CIN) operates as a private nuclear medicine imaging center with three facilities across Loire and Haute-Loire departments. The center offers a comprehensive portfolio of scintigraphy examinations (including cardiac, bone, pulmonary, thyroid, cerebral, renal, digestive, and sentinel node procedures) and PET-scan diagnostics using various radiopharmaceuticals (FDG, F-Choline, F-Dopa, PSMA, DOTATOC, FNa). CIN operates advanced medical imaging equipment including CZT semiconductor detector gamma cameras (cardiac-specific GE Discovery NM 530c and hybrid GE Discovery NM/CT 670/870 CZT) and PET/CT systems (GE Discovery PET/CT IQ). The center treats approximately 20,000 patients annually and was the first private nuclear medicine service established in France (1987).

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiac Scintigraphy Examinations Nuclear medicine diagnostic procedures for the heart, including myocardial perfusion scintigraphy (MIBI, Thallium), cardiac amyloidosis imaging, and ventricular ejection fraction ventriculography, performed using CZT gamma cameras and referred by cardiologists.
• Bone Scintigraphy and Infection Imaging Whole-body and regional skeletal visualization using HMDP tracer, with additional infection-focus imaging using NanoHSA, labeled leukocytes (CERETEC), and Scintimum tracer for infectious and inflammatory disease detection.
• Pulmonary Scintigraphy Combined ventilation (Technegas) and perfusion (macro-aggregated albumin) pulmonary imaging study for evaluating lung function and pulmonary embolism diagnosis.
• Thyroid and Parathyroid Scintigraphy Thyroid gland functional and morphological assessment using iodine-123 or technetium-99m tracers, with parathyroid adenoma localization using F-Choline PET, referred by endocrinologists.
• PET-Scan (Positron Emission Tomography) Positron emission tomography with multiple radiotracers (FDG, F-Choline, F-Dopa, Ga-68 PSMA, F-18 PSMA, Ga-68 DOTATOC, NaF) for oncology, cardiology, and neurology indications. GE Discovery PET/CT IQ equipment installed at Roanne in April 2021 and Saint-Etienne in April 2023 enables whole-body examinations in 8-10 minutes.
• Sentinel Lymph Node Detection Pre-operative scintigraphic localization of sentinel lymph nodes for surgical planning in breast cancer and melanoma.
• Digestive Scintigraphy Digestive system functional imaging including biliary tract scintigraphy, gastric emptying studies, Tektrotyd neuroendocrine lesion imaging, Meckel's diverticulum detection, gastroesophageal reflux detection, and gastrointestinal bleeding localization.
• Renal Scintigraphy Renal function and morphology assessment using technetium-labeled MAG3 (dynamic function) and DMSA (cortical morphology) tracers, referred by urologists and nephrologists.
• Cerebral Scintigraphy and Brain PET Cerebral perfusion and function scintigraphy plus F-DOPA PET for cerebral dopaminergic transmission studies, and FDG PET for cerebral hypometabolism assessment and brain tumor recurrence evaluation.
• Other Scintigraphy (Salivary, Lymphatic, Hemorrhage) Miscellaneous scintigraphic studies including salivary gland function (Tc-99m), lower-extremity lymphoscintigraphy, chylous ascites lymphatic imaging, and gastrointestinal hemorrhage detection.
• Molecular Therapies Select targeted molecular therapies using radiopharmaceuticals delivered as part of CIN's nuclear medicine service offering.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• General Electric Healthcare (GE)coreTechnology or IntegrationGeneral Electric Healthcare is the equipment supplier for CIN's imaging technology. CIN uses GE Discovery NM 530c cardiac CZT cameras, GE Discovery NM/CT 670 CZT and 870 CZT hybrid cameras, and GE Discovery PET/CT IQ PET-scan systems across all three sites.

Scale indicators4 records

Recent moves15 records

Expansion highlights6 records

Others

• GE HealthCare: Strategic technology partner supplying CIN's Discovery NM 530c, NM/CT 670/870 CZT, and Discovery PET/CT IQ systems. Comparable as a nuclear medicine ecosystem participant and equipment vendor underpinning CIN's technology platform.
• Curium Pharma: World's largest pure-play radiopharmaceutical manufacturer, supplying FDG and other PET tracers used in CIN's PET/CT scanners. Directly comparable as a nuclear-medicine ecosystem participant and key upstream supplier of CIN's inputs.
• Lantheus Holdings: US-listed radiopharmaceutical company producing diagnostic agents (e.g., Pylarify for PSMA PET) directly used in advanced PET imaging. Comparable as a peer in the nuclear medicine value chain and an upstream supplier to CIN's PSMA PET program.
• Siemens Healthineers: Major competitor to GE in PET/CT and SPECT/CT equipment. Comparable as a peer ecosystem player in the nuclear-medicine imaging equipment space that competing imaging centers in France would use.

Broad incumbents

• Synlab: Pan-European medical diagnostics services provider (laboratories and imaging). Comparable as a multi-country private diagnostics chain, though predominantly lab-focused rather than nuclear medicine specialty.
• Vivalto Santé: Third-largest French private hospital group with imaging activities at multiple sites. Comparable as a private French imaging-services operator serving similar catchment populations, though nuclear medicine is one of many service lines.
• Ramsay Santé: France's largest private hospital group, operating imaging platforms within its clinics. Comparable as a private-sector imaging provider in France, but embedded in broader hospital services rather than a standalone nuclear medicine center.
• Unilabs: European leader in clinical diagnostics and imaging with significant French footprint (acquired Inovie's stake and other networks). Overlaps with CIN in providing nuclear medicine and imaging services across multiple countries, but at much larger scale.

Direct peers

• Inovie Group: Largest French private medical biology and diagnostic imaging group. Operates a nationwide network of medical laboratories and imaging centers under SCP/holding structures, directly comparable to CIN's private diagnostic-services model in France.
• Cerba Healthcare: Major French-headquartered private diagnostics player offering specialty and routine laboratory testing across Europe. Comparable to CIN as a private specialty-diagnostics provider serving referring physicians, though heavier in lab rather than imaging.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre d’Imagerie Nucléaire